Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.4039
+0.0022 (0.55%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $8.92 million as of April 28, 2025. Its market cap has decreased by -69.57% in one year.
Market Cap
8.92M
Enterprise Value
5.21M
1-Year Change
-69.57%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $8.92M, a decrease of -84.42%. That is a compound annual growth rate of -38.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 8.92M | -35.14% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 791.26B |
| UnitedHealth Group | 380.89B |
| Johnson & Johnson | 371.02B |
| AbbVie | 330.29B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.10B |
| AstraZeneca | 215.41B |
| Novartis AG | 211.71B |